CABT yields 0.44% · ABBV yields 3.06%● Live data
📍 ABBV pulled ahead of the other in Year 1
Combined, CABT + ABBV cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CABT + ABBV for your $10,000?
Coastal Bank & Trust, a full service community bank, provides various financial products and services primarily for the retail customers and small to medium-size businesses in Onslow County and surrounding areas. The company offers personal and business checking and savings accounts; individual retirement accounts; and certificates of deposit. It also provides personal lending products, including consumer installment loans, overdraft protection services, credit cards, personal and home equity lines of credit, residential mortgage and rental property loans, residential 2nd mortgages, and home construction loans. In addition, the company offers business lending products comprising owner occupied business real estate loans, business construction loans, working capital lines of credit, agricultural and small business loans, small business start-up loans, equipment financing services, speculative or pre-sold construction loans, business credit cards, and overdraft protection services, as well as investment loans for rental real estate. Further, it provides cash management, remote deposit capture, and courier services; and SecurLOCK Equip, a mobile app to control how, when, and where debit and/or credit cards are used, as well as Zelle services. Additionally, the company offers ATM/debit cards; and online, mobile, and telephone banking services. It operates in three locations in Jacksonville, Holly Ridge, and Richlands, North Carolina. Coastal Bank & Trust was founded in 2009 and is headquartered in Jacksonville, North Carolina.
Full CABT Calculator →AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Full ABBV Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.